Speaker Fiona Cheng

[fusion_builder_container hundred_percent=”no” hundred_percent_height=”no” hundred_percent_height_scroll=”no” hundred_percent_height_center_content=”yes” equal_height_columns=”no” menu_anchor=”” hide_on_mobile=”no” status=”published” publish_date=”” class=”” id=”” background_color=”rgba(255,255,255,0.5)” background_image=”” background_position=”left top” background_repeat=”repeat” fade=”no” background_parallax=”none” enable_mobile=”no” parallax_speed=”0.3″ video_mp4=”” video_webm=”” video_ogv=”” video_url=”” video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” video_preview_image=”” border_size=”0px” border_color=”” border_style=”solid” margin_top=”” margin_bottom=”” padding_top=”0px” padding_right=”” padding_bottom=”0px” padding_left=””][fusion_builder_row][fusion_builder_column type=”2_3″ layout=”2_3″ spacing=”yes” center_content=”no” link=”” target=”_self” min_height=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=”” background_image_id=”” background_color=”” background_image=”” background_position=”left top” undefined=”” background_repeat=”no-repeat” hover_type=”none” border_size=”0″ border_color=”” border_style=”solid” border_position=”all” padding_top=”” padding_right=”” padding_bottom=”” padding_left=”” margin_top=”” margin_bottom=”” animation_type=”” animation_direction=”left” animation_speed=”0.1″ animation_offset=”” last=”no”][fusion_text columns=”” column_min_width=”” column_spacing=”” rule_style=”default” rule_size=”” rule_color=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=””]

Plenary & Workshop Speakers

[/fusion_text][/fusion_builder_column][fusion_builder_column type=”1_1″ layout=”1_1″ spacing=”yes” center_content=”no” link=”” target=”_self” min_height=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=”” background_image_id=”” background_color=”#edecec” background_image=”” background_position=”left top” undefined=”” background_repeat=”no-repeat” hover_type=”none” border_size=”0″ border_color=”transparent” border_style=”solid” border_position=”all” padding_top=”25px” padding_right=”25px” padding_bottom=”5px” padding_left=”25px” margin_top=”” margin_bottom=”” animation_type=”fade” animation_direction=”up” animation_speed=”0.3″ animation_offset=”” last=”no”][fusion_table fusion_table_type=”1″ hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=”” animation_type=”” animation_direction=”left” animation_speed=”0.3″ animation_offset=””]

	CURRENT POSITION: Chief of Department of General Surgery ,Shin Kong Wu Ho-Su Memorial Hospital Director of Breast Cancer Center, Shin Kong Wu Ho-Su Memorial Hospital Vice President,Taiwan Oncoplastic Breast Surgery Society EDUCATION: Master of Science , National Taiwan University Graduate Institute of Forensic Medicine Medical Degree, China Medical University , Taiwan SPECIALTY: Breast Specialist ( Surgeon) Surgical Specialist ( General & Gastroenterol sugery) Cancer Palliative Medicine HONORS / AWARDS: 2013 Best Paper reward From Taiwan Breast Cancer Society. SELECTED PUBLICATIONS : Expression of the serine protease, matriptase, in breast ductal carcinom Of Chinese women: Correlation with clinicopathological parameters. J.S.Jin, T.F.Cheng .W.C.Tsai, L.F.Sheu, H.Chiang, C.p.Yu.Histopathol.2007; 22:305-309. .Metronomic Therapy for Metastatic Breast Cancer: A Preliminary Report. Fiona Tsui-Fen Cheng, Yenn-Hwei Chou, Yen-Kung Chen,Sheng-Chuan His. Formos J Surg 2007; 40(2):75-80 .First-line Therapy with Lapatinib ( Tykerb) in Metastatic Breast Cancer that Progressed on Adjuvant Trastuzumab (Herceptin) Treatment: report of a case Ya-Fen Hsu, Fiona Tsui-Fen Cheng, Yen-Kung Chen, Chin-Chu Wu. Formos J Surg 2010; 43:47-52 .The Residual of Radiotracer Activity from Sentinel Lymph Scan Affects Imaging Interpretation of the whole Body Bone Scan. Yen-Chyi Chen, Chi-Tai Ku, Tsui-Fen Cheng, Yen-Kung chen. J Nucl Med Tech 2010; 7:7-10 .Outcome of Fulvestrant in Pretreated Metastatic Breast Cancer Patients in a Medical Center in Taiwan Fiona Tsui-Fen Cheng , Yang-Kong Chen. J. Cancer Res,Pract.27(1),10-18,2012 .Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer Tsui Fen Cheng ,Jung Der Wang ,Wu Ching Uen BMC Cancer 2012, 12:33 doi:10.1186/1471-2407-12-33 Cancer risk in patients with Hashimoto’s thyroiditis: a nationwide cohort study. Yen-Kung Chen, Fiona Tsui-Fen Cheng , Fung-Chang Sung, Chia-Hung Kao BRITISH JOURNAL OF CANCER，2013 oct，109(9):2496-2501 Evaluation the Availability of Cancer Tissue in Human Identity: Mutations of 15 STR Loci from Breast Cancer Tissue Fiona Tsui -Fen Cheng, Yuh-Yu Chao, Chia-Tung Shun, James Chun-I Lee The Taiwan J. of Forensic Med, 5. (2), 2013, 32 – 43 Cardio toxicity Associated with Trastuzumab Therapy in Taiwan: A Single Medical Center’s 5-Year Experience Che-Ming Chang, Fiona Tsui-Fen Cheng ,Tsen-Long Yang, Wu-Chin Wen J. Cancer Res. Pract. 2(2), 139-150, 2015 Patient Management with Eribulin in Metastatic Breast Cancer: A Clinical Practice Guide Jungsil Ro, Fiona Tsui-Fen Cheng,¹ Virote Sriuranpong,² Antonio Villalon,³ B. K Smruti,⁴ Janice Tsang,⁵ Yoon Sim Yap,⁶ and Asian Working Group for Eribulin Clinical Guide J Breast Cancer. 2016 Mar; 19(1):8-17. Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer Po-Han Lin¹,², Wen-Hung Kuo³, Ai-Chu Huang², Yen-Shen Lu⁴, Ching-Hung Lin⁴, Sung-Hsin Kuo⁴, Ming-Yang Wang³, Chun-Yu Liu⁶, Fiona Tsui-Fen Cheng⁷, Ming-Hsin Yeh⁸, Huei-Ying Li², Yu-Hsuan Yang², Yu-Hua Hsu², Sheng-Chih Fan², Long-Yuan Li⁹, Sung-Liang Yu¹⁰, King-Jen Chang¹¹, Pei-Lung Chen², Yen-Hsuan Ni^2,5, Chiun-Sheng Huang³ Oncotarget. 2016; 7:8310-8320. Pazopanib Sensitivity in a Patient with Breast Cancer and FGFR1 Amplification Fiona Tsui-Fen Cheng, Fu Ou-Yang, Nina Lapke, Kai-Che Tung, Yen-Kung, Yuh-Yu Chou, Chen, and Shu-Jen Chen J Natl Compr Canc Netw 2017;15:1456-1459; Multi-center study on patient selection for and the oncologic safety of intraoperative radiotherapy (IORT) with the Xoft Axxent® eBx® System for the management of early stage breast cancer in Taiwan. Lai HW^1,^2,3, Liu LC⁴^,5, Ouyang F^6,7,8, Yao CC^9,10, Jan HC¹¹, Chang YH¹¹, Tu CW¹², Chen DR^2,10, Cheng TF¹³, Tzeng YD¹⁴, Hsu HM¹⁵, Yeh MH^9,10, Wu YC^4,5, Yang PS^16,17, Lam HB^16,17, Hou MF^7,8,18, Chen FM^6,7,8. PLoS One. 2017; 12(11): e0185876. Intra-Operative Radiotherapy in Breast Conserving Surgery—Cases Analysis (2015-2018). Ching-Shya Yong¹, Fiona Tsui-Fen Cheng¹*, Hui-Lin Ko² World Journal of Cancer Research.2018,8(2),69-74
	ABSTRACT: My personal experience of learning and performing robotic mastectomy: experience from a non-endoscopic operating oncoplastic breast surgeon When the trend of robotic surgery swept, the breast surgeon was not included. Considering that the breast is a superficial organ, it seems unnecessary to use the robotic arm in a mastectomy. 2018 Apr ~2019 Apr, 43 patients with 47 Robotic breast reconstruction were done by a single surgeon who never perform endoscopic breast surgery. Meantime of operation for the first 7~10 patients is 343 minutes. the operation time reduces to 169 minutes for the following patients. Compare to traditional operation for immediate breast implant reconstruction, the operation time is slightly increased around 30~40 minutes. Post operation complication rate is less than the traditional method probably of less blood loss, smaller incision scar and less skin flap/pectoral muscle traction during operation. Although the robotic arm effectively reduces the physical load of the surgeon, the surgeon’s skill in using robotic arm is the most important factor for success.

CURRENT POSITION:
Chief of Department of General Surgery ,Shin Kong Wu Ho-Su Memorial Hospital
Director of Breast Cancer Center, Shin Kong Wu Ho-Su Memorial Hospital
Vice President,Taiwan Oncoplastic Breast Surgery Society

EDUCATION:
Master of Science , National Taiwan University Graduate Institute of Forensic Medicine
Medical Degree, China Medical University , Taiwan

SPECIALTY:
Breast Specialist ( Surgeon)
Surgical Specialist ( General & Gastroenterol sugery)
Cancer Palliative Medicine

HONORS / AWARDS:
2013 Best Paper reward From Taiwan Breast Cancer Society.

SELECTED PUBLICATIONS :
Expression of the serine protease, matriptase, in breast ductal carcinom
Of Chinese women: Correlation with clinicopathological parameters.
J.S.Jin, T.F.Cheng .W.C.Tsai, L.F.Sheu, H.Chiang, C.p.Yu.Histopathol.2007; 22:305-309.

.Metronomic Therapy for Metastatic Breast Cancer: A Preliminary Report. Fiona Tsui-Fen Cheng, Yenn-Hwei Chou, Yen-Kung Chen,Sheng-Chuan His. Formos J Surg 2007; 40(2):75-80

.First-line Therapy with Lapatinib ( Tykerb) in Metastatic Breast Cancer that Progressed on Adjuvant Trastuzumab (Herceptin) Treatment: report of a case
Ya-Fen Hsu, Fiona Tsui-Fen Cheng, Yen-Kung Chen, Chin-Chu Wu. Formos J Surg 2010; 43:47-52

.The Residual of Radiotracer Activity from Sentinel Lymph Scan Affects Imaging Interpretation of the whole Body Bone Scan.
Yen-Chyi Chen, Chi-Tai Ku, Tsui-Fen Cheng, Yen-Kung chen. J Nucl Med Tech 2010; 7:7-10

.Outcome of Fulvestrant in Pretreated Metastatic Breast Cancer Patients in a Medical Center in Taiwan
Fiona Tsui-Fen Cheng , Yang-Kong Chen. J. Cancer Res,Pract.27(1),10-18,2012

.Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer
Tsui Fen Cheng ,Jung Der Wang ,Wu Ching Uen
BMC Cancer 2012, 12:33 doi:10.1186/1471-2407-12-33

Cancer risk in patients with Hashimoto’s thyroiditis: a nationwide cohort study.
Yen-Kung Chen, Fiona Tsui-Fen Cheng , Fung-Chang Sung, Chia-Hung Kao
BRITISH JOURNAL OF CANCER，2013 oct，109(9):2496-2501

Evaluation the Availability of Cancer Tissue in Human Identity: Mutations of 15 STR Loci from Breast Cancer Tissue
Fiona Tsui -Fen Cheng, Yuh-Yu Chao, Chia-Tung Shun, James Chun-I Lee
The Taiwan J. of Forensic Med, 5. (2), 2013, 32 – 43

Cardio toxicity Associated with Trastuzumab Therapy in Taiwan: A Single Medical Center’s 5-Year Experience
Che-Ming Chang, Fiona Tsui-Fen Cheng ,Tsen-Long Yang, Wu-Chin Wen
J. Cancer Res. Pract. 2(2), 139-150, 2015

Patient Management with Eribulin in Metastatic Breast Cancer: A Clinical Practice Guide
Jungsil Ro, Fiona Tsui-Fen Cheng,¹ Virote Sriuranpong,² Antonio Villalon,³ B. K Smruti,⁴ Janice Tsang,⁵ Yoon Sim Yap,⁶ and Asian Working Group for Eribulin Clinical Guide
J Breast Cancer. 2016 Mar; 19(1):8-17.
Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer
Po-Han Lin¹,², Wen-Hung Kuo³, Ai-Chu Huang², Yen-Shen Lu⁴, Ching-Hung Lin⁴, Sung-Hsin Kuo⁴, Ming-Yang Wang³, Chun-Yu Liu⁶, Fiona Tsui-Fen Cheng⁷, Ming-Hsin Yeh⁸, Huei-Ying Li², Yu-Hsuan Yang², Yu-Hua Hsu², Sheng-Chih Fan², Long-Yuan Li⁹, Sung-Liang Yu¹⁰, King-Jen Chang¹¹, Pei-Lung Chen², Yen-Hsuan Ni^2,5, Chiun-Sheng Huang³
Oncotarget. 2016; 7:8310-8320.
Pazopanib Sensitivity in a Patient with Breast Cancer and FGFR1 Amplification
Fiona Tsui-Fen Cheng, Fu Ou-Yang, Nina Lapke, Kai-Che Tung, Yen-Kung, Yuh-Yu Chou, Chen, and Shu-Jen Chen
J Natl Compr Canc Netw 2017;15:1456-1459;
Multi-center study on patient selection for and the oncologic safety of intraoperative radiotherapy (IORT) with the Xoft Axxent® eBx® System for the management of early stage breast cancer in Taiwan.
Lai HW^1,^2,3, Liu LC⁴^,5, Ouyang F^6,7,8, Yao CC^9,10, Jan HC¹¹, Chang YH¹¹, Tu CW¹², Chen DR^2,10, Cheng TF¹³, Tzeng YD¹⁴, Hsu HM¹⁵, Yeh MH^9,10, Wu YC^4,5, Yang PS^16,17, Lam HB^16,17, Hou MF^7,8,18, Chen FM^6,7,8.
PLoS One. 2017; 12(11): e0185876.

Intra-Operative Radiotherapy in Breast Conserving Surgery—Cases Analysis (2015-2018).
Ching-Shya Yong¹, Fiona Tsui-Fen Cheng¹*, Hui-Lin Ko² World Journal of Cancer Research.2018,8(2),69-74

ABSTRACT:

My personal experience of learning and performing robotic mastectomy: experience from a non-endoscopic operating oncoplastic breast surgeon

When the trend of robotic surgery swept, the breast surgeon was not included.
Considering that the breast is a superficial organ, it seems unnecessary to use the robotic arm in a mastectomy.

2018 Apr ~2019 Apr, 43 patients with 47 Robotic breast reconstruction were done by a single surgeon who never perform endoscopic breast surgery.

Meantime of operation for the first 7~10 patients is 343 minutes. the operation time reduces to 169 minutes for the following patients.

Compare to traditional operation for immediate breast implant reconstruction, the operation time is slightly increased around 30~40 minutes. Post operation complication rate is less than the traditional method probably of less blood loss, smaller incision scar and less skin flap/pectoral muscle traction during operation.
Although the robotic arm effectively reduces the physical load of the surgeon, the surgeon’s skill in using robotic arm is the most important factor for success.

[/fusion_table][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]